Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$4.71
NASDAQLPCN
Open
$4.73
Change
-$0.05 (-1.05%)
Day's Range
$4.64 - $4.98
52-Week Range
$2.38 - $11.79
Volume
5.3K
Market Cap
$25.2M
Currency in USD.
Quote data delayed by at least 15 minutes.